| |
Professor Stuart Hazell PhD (NSW), MASM GAICD
Managing Director
Fusidium Pty Ltd
Stuart has more than 30 years experience in biomedical science. This includes research, consulting within the biomedical industry and senior management at the level of Dean within the university sector.
In 2002 Stuart joined the public company Panbio Ltd as Vice President, Research and Development and was responsible for reorganising the company’s research and development activities to provide clear direction and outcomes in the core business and advanced technologies. Stuart played a pivotal role in securing the rights to intellectual property that underpinned the Advanced Technologies Division within Panbio, which was developing new platform technologies.
Stuart was promoted to the position of Chief Operating Officer in May 2005 and led a number of significant improvements in operational areas of Panbio. In 2006 Stuart was appointed Acting Chief Executive Officer and formally became Chief Executive Officer in 2007. Stuart was actively involved in setting the strategic direction of Panbio and the company achieved growing profits in financial years 2006 and 2007 following significant losses in the years preceding. Inverness Medical Innovations Inc acquired Panbio in January 2008 for approximately $42 million.
Stuart is currently the Managing Director of Fusidium Pty Ltd and is engaged in consulting activities, including strategic planning and business development within the biotechnology sector.
Stuart maintains an active involvement in the broader biomedical community. He is on the Industry Advisory Panel of the Faculty of Biological and Chemical Sciences at the University of Queensland. He is on the Board of Research Australia Ltd., an organisation engaged in promoting investment in basic and applied health and medical research. Stuart is also Chair of the Advisory Panel of Rapid Diagnostics Pty Ltd., a spinout of the Environmental Biotechnology CRC.
|
|